Despite improved antimicrobial therapy and preventative practices, hospital acquired and ventilator associated pneumonia remain important causes of morbidity and mortality

HAP & VAP continues to challenge intensivists, microbiologists, ID physicians and laboratory staff alike, from initial diagnosis to choice of effective treatment regimens.

Presentation Details Downloads
Diagnosis, definitions & treatment

Welcome and Overview

Bob Masterton, Ayrshire

Download Video

Diagnosis & defi nitions of HAP/VAP – where are we now?

Gary French, London

Download Video
Download Slides

Treatment of HAP/VAP – strategies & challenges

Ethan Rubinstein, Canada

Download Video
Download Slides
Reducing patient harm

HAP/VAP care bundle interventions – a UK approach

Bob Masterton, Ayrshire

Download Video
Download Slides

Reducing patient harm in critical care: the matching Michigan experience

Bradford Winters, Baltimore, USA

Download Video
Download Slides
Advances in HAP/VAP management

The impact of non-antimicrobial interventions

Duncan Wyncoll, London

Download Video
Download Slides

The impact of recent antimicrobial interventions – the PK/PD debate & what the evidence says

William Hope, Manchester

Download Video
Download Slides

Novel biomarkers for infection & sepsis

Paul Dark, Manchester

Download Video

Event details

2 September

Royal College of Physicians, Edinburgh

GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?

Top